Ultragenyx Pharmaceu (NQ: RARE )
58.98
+1.28
(+2.22%)
Streaming Delayed Price
Updated: 12:36 PM EDT, Sep 19, 2024
Add to My Watchlist
Headline News about Ultragenyx Pharmaceu
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
August 06, 2024
Via Benzinga
Topics
Lawsuit
Via Benzinga
Via Benzinga
Analyst Scoreboard: 8 Ratings For Ultragenyx Pharmaceutical
March 18, 2024
Via Benzinga
Recap: Ultragenyx Pharmaceutical Q4 Earnings
February 15, 2024
Via Benzinga
The Latest Analyst Ratings For Ultragenyx Pharmaceutical
February 15, 2024
Via Benzinga
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
April 15, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Preview: Ultragenyx Pharmaceutical's Earnings
February 14, 2024
Via Benzinga
4 Analysts Have This To Say About Ultragenyx Pharmaceutical
January 19, 2024
Via Benzinga
Expert Ratings for Ultragenyx Pharmaceutical
December 08, 2023
Via Benzinga
Analyst Ratings for Ultragenyx Pharmaceutical
November 03, 2023
Via Benzinga
Earnings Outlook For Ultragenyx Pharmaceutical
November 01, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.